Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care Patients

NCT05341258 is registered in ClinicalTrials.gov with Gaziosmanpasa Research and Education Hospital as lead sponsor.

NCT NCT05341258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05341258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arterial and End-Tidal CO2 Gradient as a Mortality Predictor in Critical Care Patients
Lead sponsor
Gaziosmanpasa Research and Education Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2022
Completion date
August 1, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd, critical illness, pulmonary embolism, shock, trauma, ventilation perfusion mismatch